Switch theme
Sign up to access all valuation multiples
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
1993
1.3K+
Last FY Revenue $130M
Last FY EBITDA $5.3M
$62.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Mercator Medical achieved revenue of $130M and an EBITDA of $5.3M.
Mercator Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Mercator Medical valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $130M | XXX | XXX | XXX |
| Gross Profit | XXX | $18.8M | XXX | XXX | XXX |
| Gross Margin | XXX | 14% | XXX | XXX | XXX |
| EBITDA | XXX | $5.3M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 4% | XXX | XXX | XXX |
| EBIT | XXX | -$26.2M | XXX | XXX | XXX |
| EBIT Margin | XXX | -20% | XXX | XXX | XXX |
| Net Profit | XXX | -$5.5M | XXX | XXX | XXX |
| Net Margin | XXX | -4% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 3, 2025, Mercator Medical's stock price is PLN 47 (or $13).
Mercator Medical has current market cap of PLN 432M (or $120M), and EV of PLN 224M (or $62.2M).
See Mercator Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $62.2M | $120M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 3, 2025, Mercator Medical has market cap of $120M and EV of $62.2M.
Mercator Medical's trades at 0.5x EV/Revenue multiple, and 11.7x EV/EBITDA.
Equity research analysts estimate Mercator Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mercator Medical's P/E ratio is not available.
See valuation multiples for Mercator Medical and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $120M | XXX | $120M | XXX | XXX | XXX |
| EV (current) | $62.2M | XXX | $62.2M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 11.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -2.4x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -22.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -5.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMercator Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $36K for the same period.
Mercator Medical's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mercator Medical's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mercator Medical and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $36K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Ansell | XXX | XXX | XXX | XXX | XXX | XXX |
| Polymed | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| Etropal | XXX | XXX | XXX | XXX | XXX | XXX |
| Sopharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mercator Medical acquired XXX companies to date.
Last acquisition by Mercator Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Mercator Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Mercator Medical founded? | Mercator Medical was founded in 1993. |
| Where is Mercator Medical headquartered? | Mercator Medical is headquartered in Poland. |
| How many employees does Mercator Medical have? | As of today, Mercator Medical has 1.3K+ employees. |
| Is Mercator Medical publicy listed? | Yes, Mercator Medical is a public company listed on WAR. |
| What is the stock symbol of Mercator Medical? | Mercator Medical trades under MRC ticker. |
| When did Mercator Medical go public? | Mercator Medical went public in 2014. |
| Who are competitors of Mercator Medical? | Similar companies to Mercator Medical include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal. |
| What is the current market cap of Mercator Medical? | Mercator Medical's current market cap is $120M |
| Is Mercator Medical profitable? | Yes, Mercator Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
